Rare Care Chronicles is a podcast series by the TANGO2 Research Foundation covering many topics including rare disease care, research, and experiences.

Rare Care Chronicles
Claim This Podcastby TANGO2 Research Foundation
Podcast Authority
Beta
Podcast Overview
Rare Care Chronicles is a podcast series by the TANGO2 Research Foundation covering many topics including rare disease care, research, and experiences.
Language
🇺🇲
Publishing Since
7/11/2024
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Rare Care Chronicles
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

May 11, 2026
Parent Roundtable
<p><strong>Rare Care Chronicles: Parent Roundtable</strong> brings together TANGO2 parents David Longman, Amanda Hull, and Amy Clay for an honest conversation about the TANGO2 diagnosis journey. Hosted by T2RF Executive Director Ann Geffen, this episode explores early symptoms, the long search for answers, the impact of receiving a diagnosis, and how families find support, hope, and connection through the TANGO2 community.</p><p></p>

May 16, 2025
Veronica and Tyson's Story
<p>Isabella Riezler, Science Communications Manager at the Chan Zuckerberg Initiative (CZI), volunteered her time and talents to support the TANGO2 Research Foundation by capturing the story of this year's Ambassador Family: the Swetek-Jones family.In this heartfelt video, Veronica and Tyson share their journey to find a diagnosis for their daughter, Thea, and how that path led them to create the TANGO2 Family Facebook group—a vital space offering connection, information, and support for families impacted by TANGO2 Deficiency Disorder (TDD) around the world.<br>_____________________________________________________________For more information, go to: <a href="https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqbU54TmhsVDk2NTJBekxlZjRzclJQVXh2VW1YZ3xBQ3Jtc0trcUZOTUN4eHNPeWdLQy05TDVTUFU1WUhTWkl5VXpuY0VCdFdOTGdWV0lKMEg2LTgxbFlJY2l2QzNaa0VPYlZ4c1NDRWI4VjdGT1hQTTFXUkhDRzM4SF8yVXFzZlRxTS16bXItUzhKZFBZbHNrb1RaUQ&q=https%3A%2F%2Ftango2research.org%2F&v=IE_J_XcmiFc" target="_blank" rel="nofollow">https://tango2research.org/</a>Find us on Facebook: / tango2research Find us on Twitter: / tango2research Find us on Instagram: / tango2researchfoundation Find us on LinkedIn: / tango2-research-foundation</p>

October 1, 2024
"Can We Fix It?" by Kasha Morris
<p>This is a story about fixing an impossible problem in an unexpected way.</p> <p><em>Kasha Morris is a retired teacher that co-founded the TANGO2 Research Foundation with her husband Mike in 2018 after a fifteen-year diagnostic journey for their son Ryan. Faced with the reality of a life-limiting ultra rare genetic condition they got to work to help their son. Although TANGO2 was newly discovered, their search would take them back twenty years to uncover some answers in an unexpected place.</em> </p> <p> To learn more, visit <a href="http://www.tango2research.org/" rel="ugc noopener noreferrer" target="_blank">www.tango2research.org</a>. Find us on Facebook: <a href="https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqbnhHUUhtcUJpVmdLMmdPOTRfU0gxYjF2aXJpQXxBQ3Jtc0ttc00tendFd2JtRm5lb1BsRmhlRVREQklja1QzdzJ4ZW5PNlhvek1UOUpNa28yUzk5RnlFZmNiOVlpenpQMFYtdDVvbFVCRUw4aVJBeHVVSzZjWTM2eEdtWUNSbXNCSVBLem5ZVWVUODhtODdoNWRDbw&q=https%3A%2F%2Fwww.facebook.com%2Ftango2research&v=SjX5QGwbPUs" rel="ugc noopener noreferrer" target="_blank"> / tango2research </a> Find us on X: <a href="https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqbnEwMFFydGl3SWI0N0ZuVlVUX1I5clRoZGs2QXxBQ3Jtc0trZktLTU1Ed0l0Qmpjdy1IVExiTHNCTkozamE3UjdGWlY1MUZydEhsZFIxTWtVMlRsOVVENWVNSlhwQ0hnZGp3MDJlLVRpdzE5bHZrX0pwZFJLekxGbDd2b250REZfdFdnbEVaQTQwbTZELThtRXFVcw&q=https%3A%2F%2Ftwitter.com%2Ftango2research&v=SjX5QGwbPUs" rel="ugc noopener noreferrer" target="_blank"> / tango2research </a> Find us on Instagram: <a href="https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqbTNLMllzZlctcG5BSGZmUTVZWkhLVGJvZGJiUXxBQ3Jtc0tuOU9KOU1qTUViQ2YxdTZldkFfNHRWaFd2TzB2dUFza3Q0bms2ZWdqNmtjZ3J5TnFNX25sMDFGT2ZJc0pvVEl4cHhsN3YtamJNQ0l6OWZ4cWwwUXFnbjg2U29CekdsY3o5WE8yRzJRR19SNUVObDJjZw&q=https%3A%2F%2Fwww.instagram.com%2Ftango2researchfoundation%2F&v=SjX5QGwbPUs" rel="ugc noopener noreferrer" target="_blank"> / tango2researchfoundation </a> Find us on LinkedIn: <a href="https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqbDFCYksyR3FUQldSOFpYYXNRRmk3RmlDTjBhd3xBQ3Jtc0tud1JkVjVRVEFRZEVpTHBHMTE5RkxVa3B5amxWYkpWdkFOU2NVbnpBM05SaVJmQzQ2QmFDbDNyT3FTRGVlbnY5Y2cyakdiNTB3V2NrdUF3RW03cDVUcE1GNXRURUtNVnRTWnVZTGY5TjhhUm80WktnZw&q=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftango2-research-foundation%2F&v=SjX5QGwbPUs" rel="ugc noopener noreferrer" target="_blank"> / tango2-research-foundation </a> </p>
10 total episodes available
Deep-dive analytics for Rare Care Chronicles
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Rare Care Chronicles?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.